載入...
Invariant NKT cell activation induces neutrophil accumulation and hepatitis: oppositely regulated by IL-4 and IFN-γ
Alpha-Galactosylceramide (α-Galcer), a specific agonist for invariant natural killer T (iNKT) cells, is being evaluated in clinical trials for the treatment of viral hepatitis and liver cancer. However, the results from α-Galcer treatment are mixed, partially because of the variety of cytokines prod...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3758807/ https://ncbi.nlm.nih.gov/pubmed/23686838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.26471 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|